Skip to main content
Lori M. Gawron
No Rating Available
(Learn About Our Rating System)

Lori M. Gawron, MD, MPH, FACOG

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Women's Health, Area E
50 N Medical Dr
Salt Lake City , UT 84132
  • Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Professor (Clinical)

    Education history

    Undergraduate Biological Sciences and Nursing - St. Clair County Community College A.D.N.
    Undergraduate Biology - Wayne State University B.S.
    Professional Medical Medicine - Northwestern University Feinberg School of Medicine M.D.
    Residency Obstetrics and Gynecology - Northwestern University Feinberg School of Medicine Resident
    Fellowship Family Planning and Contraception - Northwestern University Feinberg School of Medicine Fellow
    Graduate Training Public Health - Northwestern University M.P.H.
    Certification Biomedical Informatics - University of Utah Postgraduate Certificate

    Selected Publications

    Journal Article

    1. Turok DK, Leeman L, Sanders JN, Thaxton L, Eggebroten JL, Yonke N, Bullock H, Singh R, Gawron LM, Espey (2017). Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial. American journal of obstetrics and gynecology, 217(6), 665.e1-665.e8. (Read full publication)
    2. Sanders JN, Gawron LM, Friedman (2016). Sexual satisfaction and inflammatory bowel diseases: an interdisciplinary clinical challenge. American journal of obstetrics and gynecology, 215(1), 58-62. (Read full publication)
    3. Sanders JN, Myers K, Gawron LM, Simmons RG, Turok D (2018). Contraceptive Method Use During the Community-Wide HER Salt Lake Contraceptive Initiative. American journal of public health, 108(4), 550-556. (Read full publication)
    4. Gawron LM, Hammond C, Ernst L (2013). Perinatal pathologic examination of nonintact, second-trimester fetal demise specimens: the value of standardization. Archives of pathology & laboratory medicine, 137(8), 1083-7. (Read full publication)
    5. Sanders JN, Higgins JA, Adkins DE, Stoddard GJ, Gawron LM, Turok D (2018). The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 Year. Women's health issues, 28(5), 401-407. (Read full publication)
    6. Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond (2012). Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception, 86(6), 704-9. (Read full publication)
    7. Mody SK, Kiley J, Gawron L, Garcia P, Hammond (2013). Team-based learning: a novel approach to medical student education in family planning. Contraception, 88(2), 239-42. (Read full publication)
    8. Gawron LM, Cameron KA, Phisuthikul A, Simon M (2013). An exploration of women's reasons for termination timing in the setting of fetal abnormalities. Contraception, 88(1), 109-15. (Read full publication)
    9. Gawron LM, Gawron AJ, Kasper A, Hammond C, Keefer (2014). Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey. Contraception, 89(5), 419-25. (Read full publication)
    10. Gawron LM, Simmons RG, Sanders JN, Myers K, Gundlapalli AV, Turok D (2020). The effect of a no-cost contraceptive initiative on method selection by women with housing insecurity. Contraception, 101(3), 205-209. (Read full publication)
    11. Sanders JN, Turok DK, Royer PA, Thompson IS, Gawron LM, Storck K (2017). One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Contraception, 96(2), 99-105. (Read full publication)
    12. Gawron LM, Kiley J (2013). Labor induction outcomes in third-trimester stillbirths. International journal of gynaecology and obstetrics, 123(3), 203-6. (Read full publication)
    13. Gawron LM, Sanders JN, Sward K, Poursaid AE, Simmons R, Turok D (2019). Multi-morbidity and Highly Effective Contraception in Reproductive-Age Women in the US Intermountain West: a Retrospective Cohort Study. Journal of general internal medicine, 35(3), 637-642. (Read full publication)
    14. Gawron LM, Redd A, Suo Y, Pettey W, Turok DK, Gundlapalli A (2017). Long-acting Reversible Contraception Among Homeless Women Veterans With Chronic Health Conditions: A Retrospective Cohort Study. Medical care, 55 Suppl 9 Suppl 2, S111-S120. (Read full publication)
    15. Gawron LM, Hammond C, Keefer (2014). Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases. Patient education and counseling, 94(1), 134-7. (Read full publication)
    16. Gawron LM, Goldberger A, Gawron AJ, Hammond C, Keefer (2014). The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases. Inflammatory bowel diseases, 20(10), 1729-33. (Read full publication)
    17. Gawron LM, Mohanty AF, Kaiser JE, Gundlapalli A (2018). Impact of Deployment on Reproductive Health in U.S. Active-Duty Servicewomen and Veterans. Seminars in reproductive medicine, 36(6), 361-370. (Read full publication)
    18. Sanders JN, Adkins DE, Kaur S, Storck K, Gawron LM, Turok D (2018). Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study. PloS one, 13(11), e0199724. (Read full publication)
    19. Gawron LM, Pettey WBP, Redd AM, Suo Y, Turok DK, Gundlapalli A (2019). Distance Matters: Geographic barriers to long acting reversible and permanent contraception for homeless women Veterans. Journal of social distress and the homeless, 28(2), 139-148. (Read full publication)
    20. Turok DK, Simmons RG, Cappiello B, Gawron LM, Saviers-Steiger J, Sanders J (2018). Use of a novel suction cervical retractor for intrauterine device insertion: a pilot feasibility trial. BMJ sexual & reproductive health, (Read full publication)

    Review

    1. Ernst LM, Gawron L, Fritsch M (2013). Pathologic examination of fetal and placental tissue obtained by dilation and evacuation. Archives of pathology & laboratory medicine, 137(3), 326-37. (Read full publication)

    Case Report

    1. Gawron LM, Goldman KN, Kiley J (2013). A gravid development: should the desire to maintain fertility determine treatment for profuse bleeding in pregnancy? Am J Obstet Gynecol, 208(4), 332.e1-2. (Read full publication)

    Letter

    1. Gawron LM, Gero A, Kushner KL, Turok DK, Sanders J (2019). Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception. American journal of obstetrics and gynecology, 222(4S), S891-S892. (Read full publication)

    Abstract

    1. Gawron LM, Hammond C, Keefer (2013). Documentation of reproductive health counseling and contraception in women with inflammatory bowel disease. 155(5), S-198.
    2. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer (2014). The Effect of Hormonal Contraceptives on Menstrual-Related Inflammatory Bowel Disease Symptoms. 146(5), S-552.
    3. Kasper A, Keefer L, Gawron AJ, Gossett, DR, Hahn EA, Gawron L (2014). Fertility-Related Knowledge in Women with Inflammatory Bowel Disease. 146(5), S-370.
    4. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer (2014). Disease-related Pregnancy Concerns and Reproductive Planning in Women with Inflammatory Bowel Disease. 146(5), S-195.